Roche relaunches refillable wet AMD implant two years after recall
Two years following a voluntary recall, Roche has relaunched Susvimo (ranibizumab injection) for use as an ocular implant for the…
Two years following a voluntary recall, Roche has relaunched Susvimo (ranibizumab injection) for use as an ocular implant for the…
Digital health company AEYE Health, in collaboration with handheld retinal imaging devices provider Optomed, will launch an autonomous diabetic retinopathy…
Light field technology company Evolution Optiks has secured 510(k) clearance from the US Food and Drug Administration (FDA) for its…
Sight Sciences revealed additional long-term data supporting its TearCare device for the treatment of dry eye disease, indicating it could…
Eye health company Bausch + Lomb has secured regulatory approval from Health Canada for its enVista Envy full visual range…
The US Food and Drug Administration (FDA) has qualified the American Academy of Ophthalmology's patient-reported outcome measure for Assessment of…
Optomed USA has launched Optomed Aurora AEYE, a handheld AI fundus camera designed to instantly detect more than mild diabetic…
US-based regents manufacturer Bio-Techne, in collaboration with Novomol-Dx, has announced the development of a new ocular biomarker assay, Bio-Marker Pathfinder…
Science Corporation, a brain-computer interface technology company, has announced the acquisition of intellectual property and related assets for the Prima…
Pantheon Vision has completed two pre-submission meetings with the US Food and Drug Administration (FDA) as the company looks to…